- Nelivaptan
-
Nelivaptan Systematic (IUPAC) name (2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxo-indolin-3-yl]-4-hydroxy-N,N-dimethyl-pyrrolidine-2-carboxamide Clinical data Pregnancy cat. ? Legal status ? Routes Oral Identifiers CAS number 439687-69-1 ATC code None PubChem CID 9895468 ChemSpider 8071134 UNII 3TY57MQ4OA ChEMBL CHEMBL582857 Chemical data Formula C30H32ClN3O8S Mol. mass 630.11 g/mol (what is this?) (verify) Nelivaptan (INN[1]), codenamed SSR-149,415, is a selective and orally active non-peptide vasopressin receptor antagonist selective for the V1b subtype.[2] The drug had entered clinical trials for treatment of anxiety and depression.[3] In July 2008, Sanofi-Aventis announced that further development of this drug had been halted.[4]
References
- ^ World Health Organization (2007). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 98". WHO Drug Information 21 (4): 341. http://www.who.int/medicines/publications/druginformation/innlists/P-List98.pdf.
- ^ Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P (2002). "Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders". Proc. Natl. Acad. Sci. U.S.A. 99 (9): 6370–5. doi:10.1073/pnas.092012099. PMC 122955. PMID 11959912. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=122955.
- ^ Serradeil-Le Gal C, Wagnon J, Tonnerre B, Roux R, Garcia G, Griebel G, Aulombard A (2005). "An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders". CNS drug reviews 11 (1): 53–68. doi:10.1111/j.1527-3458.2005.tb00035.x. PMID 15867952.
- ^ "Second-quarter 2008 results". Press Release. Sanofi-Aventis. 2008-07-31. http://en.sanofi-aventis.com/binaries/20080731_results2008_Q2_CP_EN_tcm28-20271.pdf. Retrieved 2009-06-10. "It has been decided to discontinue the development of amibegron and SSR 149415 (a V1B receptor antagonist)."
External links
Hypothalamic-pituitary hormones and analogues (H01) Hypothalamic Agonists: Lanreotide • OctreotideAnterior pituitary Agonists: Corticotropin • Cosyntropin • TetracosactideAgonists: ThyrotropinPosterior pituitary Agonists: Argipressin • Desmopressin • Felypressin • Lypressin • Ornipressin • Terlipressin
Antagonists: Conivaptan • Demeclocycline • Lixivaptan • Mozavaptan • Nelivaptan • Relcovaptan • Satavaptan • TolvaptanNeuropeptidergics Cholecystokinin Agonists: Cholecystokinin • CCK-4
Antagonists: Asperlicin • Proglumide • Lorglumide • Devazepide • DexloxiglumideCRH Agonists: Corticotropin releasing hormoneGalanin Agonists: Galanin • Galanin-like peptide • Galmic • GalnonAgonists: Galanin • Galanin-like peptide • Galmic • GalnonAgonists: Galanin • Galmic • GalnonGhrelin MCH Agonists: Melanin concentrating hormone
Antagonists: ATC-0175 • GW-803,430 • NGD-4715 • SNAP-7941 • SNAP-94847Agonists: Melanin concentrating hormoneMelanocortin Agonists: alpha-MSH • Afamelanotide • Bremelanotide • Melanotan II
Antagonists: Agouti signalling peptideAgonists: alpha-MSH • Bremelanotide • Melanotan IIAgonists: alpha-MSH • Melanotan IINeuropeptide S Agonists: Neuropeptide S
Antagonists: SHA-68Neuropeptide Y Neurotensin Opioid see Template:OpioidsOrexin Oxytocin Agonists: Carbetocin • Demoxytocin • Oxytocin • WAY-267,464
Antagonists: Atosiban • Epelsiban • L-371,257 • L-368,899Tachykinin Agonists: Substance P
Antagonists: Aprepitant • Befetupitant • Casopitant • CI-1021 • CP-96,345 • CP-99,994 • CP-122,721 • Dapitant • Ezlopitant • FK-888 • Fosaprepitant • GR-203,040 • GW-597,599 • HSP-117 • L-733,060 • L-741,671 • L-743,310 • L-758,298 • Lanepitant • LY-306,740 • Maropitant • Netupitant • NKP-608 • Nolpitantium • Orvepitant • RP-67,580 • SDZ NKT 343 • Vestipitant • VofopitantVasopressin Agonists: Desmopressin • Felypressin • Ornipressin • Terlipressin • Vasopressin
Antagonists: Conivaptan • Demeclocycline • RelcovaptanAgonists: Felypressin • Ornipressin • Terlipressin • Vasopressin
Antagonists: Demeclocycline • NelivaptanAgonists: Desmopressin • Ornipressin • Vasopressin
Antagonists: Conivaptan • Demeclocycline • Lixivaptan • Mozavaptan • Satavaptan • TolvaptanThis hormonal preparation article is a stub. You can help Wikipedia by expanding it.